<DOC>
	<DOCNO>NCT01025739</DOCNO>
	<brief_summary>Objectives Study : The primary objective study evaluate relative merit , safety effectiveness tailor TIF2 procedure treat GERD patient persistent GERD symptom despite PPI therapy . The secondary objective study evaluate effectiveness tailor TIF procedure restore antireflux barrier eliminate GE reflux . Type Study : Prospective , non-randomized , uncontrolled Study Duration 12 month Number Patients 20 Inclusion Criteria : Age 18-70 year , daily PPIs &gt; 6 month , persistent GERD symptom despite PPI therapy , anatomic disruption gastroesophageal valve Hill Grade II-III , evidence one follow PPI therapy : ( 1 ) erosive esophagitis ( erosion ulceration endoscopy ) ; ( 2 ) abnormal ambulatory pH study ; ( 3 ) biopsy confirm change characteristic reflux esophagitis ; acceptable esophageal motility ( either manometry video esophagogram ) , hiatal hernia large 2 cm , patient willing cooperate post-operative dietary recommendation assessment test , sign informed consent Exclusion Criteria : BMI &gt; 40 , hiatal hernia &gt; 2 cm , esophagitis grade D , esophageal ulcer , fix esophageal stricture , gastric motility disorder , previous splenectomy , pregnancy ( female ) , immunosuppression , ASA &gt; 2 , portal hypertension and/or varix , history previous resective gastric esophageal surgery , cervical spine fusion , Zenker 's diverticulum , esophageal epiphrenic diverticulum , achalasia , scleroderma dermatomyositis , eosinophilic esophagitis , cirrhosis , active gastro-duodenal ulcer disease , gastric outlet obstruction stenosis , gastroparesis delay gastric emptying , coagulation disorder Interventions : Treatment : Tailored transoral incisionless fundoplication ( TIF2 ) use EsophyX system SerosaFuse fastener ( EndoGastric Solutions , Inc. , Redmond , WA , USA ) Evaluation Criteria : Primary Outcome Measure 24 hour pH impedance study : change Johnson DeMeester score ; GERD-HRQOL score Secondary Outcome Measures PPI usage , GERD symptoms 6 12 month vs. baseline PPI 's , total number reflux episode , Symptom Association Probability PPI . Safety : Adverse event map standard term report .</brief_summary>
	<brief_title>Evaluation Safety Effectiveness Tailored Transoral Incisionless Fundoplication ( TIF ) Using EsophyX Treatment GERD</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>Age 1870 year On daily PPIs &gt; 6 month Persistent GERD symptom despite PPI therapy Anatomic disruption gastroesophageal valve Hill Grade IIIII Evidence one follow PPI therapy : Erosive esophagitis ( erosion ulceration endoscopy ) Abnormal ambulatory pH study Biopsy confirm change characteristic reflux esophagitis Acceptable esophageal motility ( either manometry video esophagogram ) Hiatal hernia large 2 cm Patient willing cooperate postoperative dietary recommendation assessment test Signed informed consent BMI &gt; 40 Hiatal hernia &gt; 2 cm Esophagitis grade D Esophageal ulcer Esophageal stricture Esophageal motility disorder Prior splenectomy Pregnancy plan pregnancy next 12 month ( female ) Immunosuppression ASA &gt; 2 Portal hypertension and/or varix History previous resective gastric esophageal surgery , cervical spine fusion , Zenker 's diverticulum , esophageal epiphrenic diverticulum , achalasia , scleroderma dermatomyositis , eosinophilic esophagitis , cirrhosis Active gastroduodenal ulcer disease Gastric outlet obstruction stenosis Gastroparesis delay gastric emptying confirm solidphase gastric empty study patient complain postprandial satiety assessment Coagulation disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Gastroesophageal Reflux Disease ( GERD )</keyword>
	<keyword>EsophyX</keyword>
</DOC>